CervoMed Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 1.0 | 28.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.1 | 4.8 | 5.9 | 8.0 | 22.6 | 15.4 | 12.6 | 2.1 | 8.6 | 7.3 | 12.2 | 18.2 | 17.3 | 95.9 | |
| 6.3 | 2.6 | – | 27.3 | 3.9 | – | 0.8 | 0.9 | 1.0 | 0.4 | 1.0 | 0.7 | 0.7 | 0.8 | 0.6 | 1.5 | 1.9 | 2.1 | 1.4 | 1.5 | 1.4 | 0.9 | 0.8 | 0.5 | 0.5 | – | 0.5 | 0.5 | 1.8 | 5.8 | 26.9 | 3.0 | 2.8 | 0.5 | 2.3 | 1.7 | 2.9 | 4.0 | 3.4 | 1.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -16.5% | -45.5% | -23.1% | -29.8% | -47.6% | – | -54.5% | -53.3% | -46.2% | -162.8% | -81.2% | -89.4% | -117.2% | -64.0% | -96.9% | -22.1% | -23.4% | -26.5% | -19.8% | -20.7% | -28.6% | -45.9% | -55.2% | -107.9% | -44.6% | -51.5% | -24.6% | -0.9% | -24.3% | -7.6% | -2.2% | -2.3% | -8.7% | -82.6% | -23.7% | -41.3% | -33.3% | -32.1% | -76.4% | -88.1% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 22.7% | -7.2% | -54.3% | -83.2% | -184.9% | -176.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -768.8% | -554.7% | -326.6% | -144.0% | -141.1% | -111.3% | -133.8% | -187.2% | -224.9% | -315.8% | -441.7% | -706.3% | -1,488.9% | -9,407.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -687.7% | -491.4% | -132.4% | -40.0% | -65.2% | -52.2% | -118.7% | -167.3% | -200.6% | -290.8% | -415.4% | -673.1% | -1,437.8% | -9,160.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -149.6% | -4.3% | -143.6% | -60.5% | -50.6% | -35.9% | -109.5% | -169.8% | -204.1% | -299.8% | -404.7% | -585.4% | -1,319.9% | -8,444.9% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -161.7% | -196.4% | – | -1,392.4% | -90.1% | -6.4% | 80.6% | 3.0% | -52.7% | -117.7% | -137.4% | -108.4% | -100.7% | -58.6% | -64.9% | -37.2% | -48.3% | -57.2% | -30.3% | -33.7% | -64.7% | -69.0% | -78.3% | -91.5% | -54.4% | – | -59.5% | -48.6% | -40.6% | -29.4% | -77.8% | -10.1% | -26.2% | -41.6% | -53.9% | -67.6% | -98.4% | -148.0% | -282.9% | -132.2% | |
| -97.5% | -103.2% | -111.3% | -48.0% | -20.2% | -5.2% | 71.8% | 2.7% | -46.7% | -100.9% | -111.4% | -92.6% | -84.1% | -48.9% | -55.1% | -34.0% | -43.5% | -51.2% | -28.9% | -32.1% | -60.4% | -63.7% | -71.4% | -83.6% | -49.7% | -328.9% | -52.8% | -44.1% | -32.3% | -21.8% | -51.9% | -9.5% | -24.4% | -37.8% | -48.4% | -59.4% | -83.6% | -115.2% | -198.7% | -116.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -1.1 | 0.3 | -10 | -5.0 | -0.7 | -8.3 | -16 | – | – | – | -5.2 | -8.3 | -6.0 | -14 | -11 | -25 | -22 | -18 | -47 | -43 | -40 | – | – | – | – | 8.3 | -3.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 60.3% | 52.5% | -52.6% | 3.4% | 22.4% | 81.2% | 89.1% | 91.2% | 88.6% | 85.8% | 81.0% | 85.5% | 83.5% | 83.5% | 85.0% | 91.3% | 90.0% | 89.5% | 95.4% | 95.2% | 93.3% | 92.3% | 91.2% | 91.4% | 91.4% | -216.4% | 88.8% | 90.7% | 79.5% | 74.0% | 66.7% | 94.0% | 93.4% | 91.0% | 89.8% | 87.8% | 85.0% | 77.9% | 70.2% | 88.3% | |
| 0.2 | 0.2 | – | 2.1 | 0.1 | 0.0 | 0.0 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | 0.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -2,022.42 | -1,972.97 | -4,402.30 | -1,318.51 | -437.72 | – | 638.55 | 17.98 | -244.90 | -416.33 | -395.50 | -333.71 | -217.62 | -26.43 | -25.23 | -17.66 | -16.26 | -16.62 | -14.63 | -12.46 | -18.17 | -17.73 | -17.64 | -17.95 | -9.62 | -10.06 | -7.12 | -5.09 | -1.03 | -0.38 | -0.67 | -0.58 | -1.37 | -1.87 | -2.15 | -2.53 | -2.77 | -2.91 | -3.24 | -2.96 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.04 | 1.04 | 0.78 | 0.96 | 1.03 | 1.11 | 1.16 | 1.12 | 1.07 | 0.87 | 0.67 | 0.43 | 0.23 | 0.03 | |
| 1,250.55 | 1,004.67 | -2,080.59 | 94.70 | 486.02 | – | 792.04 | 607.61 | 465.11 | 353.82 | 287.79 | 307.90 | 216.03 | 45.10 | 38.91 | 47.44 | 33.66 | 29.07 | 48.23 | 36.92 | 28.06 | 25.69 | 22.53 | 19.62 | 17.70 | -6.62 | 11.97 | 10.46 | 2.54 | 1.30 | 0.86 | 5.74 | 5.24 | 4.50 | 3.98 | 3.74 | 2.81 | 1.97 | 1.15 | 2.24 | |
| -1,298.96 | -1,178.14 | -1,040.45 | -770.81 | -910.07 | – | -337.04 | -275.62 | -223.28 | -244.15 | -225.28 | -194.34 | -166.96 | -22.08 | -23.27 | -16.22 | -14.76 | -15.88 | -13.69 | -11.34 | -10.94 | -10.67 | -10.34 | -10.84 | -3.61 | -3.94 | -1.55 | -0.04 | -1.12 | -0.58 | -0.52 | -0.40 | -1.27 | -1.90 | -2.18 | -2.60 | -2.69 | -2.53 | -2.98 | -2.73 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.